12 PRIMECAP Management Spectrum Pharmaceuticals Trades
The first Spectrum Pharmaceuticals trade was made in Q3 2017. Since then PRIMECAP Management bought shares six more times and sold shares on five occasions. The investor completely sold their stake between Q3 2019 and Q3 2020.
Avg closing price
Price range
Sold -460 Thousand shares
Q3 2020
Avg closing price
$3.80
Price range
$2.99
-
$4.90
Sold 92.8% shares (-5.96 Million shares)
Q1 2020
Avg closing price
$2.74
Price range
$1.83
-
$3.45
Sold 41.5% shares (-4.56 Million shares)
Q4 2019
Avg closing price
$8.08
Price range
$3.50
-
$10.35
Sold 1.3% shares (-150 Thousand shares)
Q3 2019
Avg closing price
$8.09
Price range
$7.03
-
$9.70
Increased shares by 0.6% (+67 Thousand shares)
Q2 2019
Avg closing price
$8.94
Price range
$7.36
-
$11.26
Increased shares by 0.2% (+25.3 Thousand shares)
Q1 2019
Avg closing price
$10.71
Price range
$9.08
-
$11.84
Sold 1.1% shares (-126 Thousand shares)
Q4 2018
Avg closing price
$12.74
Price range
$6.39
-
$16.99
Increased shares by 10.2% (+1.03 Million shares)
Q3 2018
Avg closing price
$21.64
Price range
$16.52
-
$24.82
Increased shares by 36.5% (+2.71 Million shares)
Q2 2018
Avg closing price
$18.52
Price range
$14.31
-
$21.75
Increased shares by 62.5% (+2.85 Million shares)
Q1 2018
Avg closing price
$19.81
Price range
$16.09
-
$23.07
Increased shares by 14.0% (+560 Thousand shares)
Q4 2017
Avg closing price
$18.11
Price range
$13.36
-
$20.73
New holding (+4.01 Million shares)
Q3 2017
Avg closing price
$9.05
Price range
$7.28
-
$14.07
